ResMed, founded in 1989 by engineer Peter C. Farrell, is a global leader in the development and manufacture of medical devices and cloud-connected software applications for the diagnosis, treatment and management of respiratory disorders. Headquartered in San Diego, California, the company pioneered the use of continuous positive airway pressure (CPAP) therapy for sleep apnea and has since expanded its product portfolio to address a broad range of breathing-related conditions.
The company’s core product offerings include advanced CPAP and bilevel devices, mask systems and ventilators designed for both home and hospital settings. ResMed continuously invests in research and development to enhance device comfort, efficacy and connectivity, integrating sensors and algorithms that allow for real-time monitoring of patient compliance and therapy outcomes. Its ventilator line supports critical care and noninvasive ventilation, catering to patients with chronic obstructive pulmonary disease (COPD), neuromuscular and other respiratory conditions.
Operating in more than 140 countries, ResMed serves a diverse customer base spanning sleep clinics, home healthcare providers and hospitals. The company has strengthened its position in digital health through its cloud platform, which aggregates patient data for care teams and enables remote monitoring and telehealth services. This digital ecosystem fosters greater patient engagement, streamlines clinician workflows and supports value-based care models in both mature and emerging markets.
Under the leadership of CEO Mick Farrell, who succeeded the founder in 2013, ResMed has focused on innovation, strategic acquisitions and global expansion. The executive team includes seasoned professionals in engineering, clinical affairs and global distribution, reflecting the company’s commitment to advancing respiratory care. As the prevalence of sleep apnea and chronic respiratory diseases continues to rise, ResMed aims to leverage its technology and data analytics capabilities to improve patient outcomes and reduce healthcare costs worldwide.
AI Generated. May Contain Errors.
